Human Amniotic Fluid Stem Cells Ameliorate Thioglycollate-Induced Peritonitis by Increasing Tregs in Mice.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Jun 2022
Historique:
received: 22 03 2022
revised: 06 06 2022
accepted: 07 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Mesenchymal stem cells (MSCs) affect immune cells and exert anti-inflammatory effects. Human amniotic fluid stem cells (hAFSCs), a type of MSCs, have a high therapeutic effect in animal models of inflammation-related diseases. hAFSCs can be easily isolated and cultured from amniotic fluid, which is considered a medical waste. Hence, amniotic fluid can be a source of cells for MSC therapy of inflammatory diseases. However, the effect of hAFSCs on acquired immunity in vivo, especially on regulatory T cells, has not yet been fully elucidated. Therefore, in this study, we aimed to understand the effects of hAFSCs on acquired immunity, particularly on regulatory T cells. We showed that hAFSCs ameliorated the thioglycollate-induced inflammation by forming aggregates with host immune cells, such as macrophages, T cells, and B cells in the peritoneal cavity. Further, the regulatory T cells increased in the peritoneal cavity. These results indicated that, in addition to helping the innate immunity, hAFSCs could also aid the acquired immune system in vivo against inflammation-related diseases by increasing regulatory T cells.

Identifiants

pubmed: 35742877
pii: ijms23126433
doi: 10.3390/ijms23126433
pmc: PMC9224120
pii:
doi:

Substances chimiques

Thioglycolates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP19K22602
Organisme : Japan Society for the Promotion of Science
ID : JP21H03080
Organisme : Japan Society for the Promotion of Science
ID : JPMJSP2123

Références

Clin Exp Immunol. 2009 Apr;156(1):149-60
pubmed: 19210524
Stem Cell Res Ther. 2020 Jul 20;11(1):300
pubmed: 32690106
Proc Natl Acad Sci U S A. 1964 Jun;51:1158-64
pubmed: 14215638
PLoS One. 2012;7(4):e35512
pubmed: 22539976
Stem Cells. 2004;22(7):1338-45
pubmed: 15579651
Evid Based Complement Alternat Med. 2018 Aug 7;2018:4041873
pubmed: 30174703
Stem Cells. 2021 Apr;39(4):403-413
pubmed: 33432732
Clin Interv Aging. 2020 Aug 13;15:1383-1391
pubmed: 32884248
Expert Opin Biol Ther. 2008 May;8(5):569-81
pubmed: 18407762
Gastroenterology. 2015 Jul;149(1):163-176.e20
pubmed: 25790743
Blood. 2005 Feb 15;105(4):1815-22
pubmed: 15494428
Nat Rev Immunol. 2006 Apr;6(4):295-307
pubmed: 16557261
Shock. 2000 Feb;13(2):110-6
pubmed: 10670840
Stem Cells. 2003;21(1):105-10
pubmed: 12529557
Cytotherapy. 2016 Feb;18(2):160-71
pubmed: 26794710
Pediatr Surg Int. 2010 Jan;26(1):79-84
pubmed: 19855985
Bone. 1992;13(1):81-8
pubmed: 1581112
Pediatr Res. 2019 Jan;85(1):97-104
pubmed: 30120407
Curr Opin Immunol. 2011 Oct;23(5):679-84
pubmed: 21802270
Tissue Cell. 2021 Feb;68:101472
pubmed: 33360545
Int J Mol Sci. 2020 Dec 16;21(24):
pubmed: 33339379
Transpl Int. 2017 Aug;30(8):745-753
pubmed: 28012226
Tissue Eng. 2001 Apr;7(2):211-28
pubmed: 11304456
PLoS One. 2010 Feb 24;5(2):e9357
pubmed: 20195358
Stem Cell Res Ther. 2020 Feb 18;11(1):64
pubmed: 32070420
Curr Stem Cell Res Ther. 2013 Mar;8(2):125-32
pubmed: 23140502
Hum Cell. 2019 Jan;32(1):51-63
pubmed: 30506493
J Immunol. 2010 Jul 1;185(1):302-12
pubmed: 20511548
Cell Immunol. 1989 Jan;118(1):178-91
pubmed: 2910501
Exp Hematol. 2002 Jan;30(1):42-8
pubmed: 11823036
Nat Biotechnol. 2007 Jan;25(1):100-6
pubmed: 17206138
J Biomed Sci. 2016 Nov 4;23(1):76
pubmed: 27809910
Stem Cells Transl Med. 2019 Nov;8(11):1170-1179
pubmed: 31407874
Transplant Proc. 2012 Oct;44(8):2490-4
pubmed: 23026627
J Pathol. 2017 Oct;243(2):137-147
pubmed: 28722107
PLoS One. 2012;7(8):e43768
pubmed: 22912904
Stem Cell Res Ther. 2016 Feb 10;7:27
pubmed: 26864573
Stem Cells Dev. 2012 Jul 20;21(11):1911-23
pubmed: 22066606
J Leukoc Biol. 2009 Aug;86(2):361-70
pubmed: 19414540
J Surg Res. 1990 Aug;49(2):186-96
pubmed: 2199735
Shock. 2007 Nov;28(5):504-17
pubmed: 17589378
Front Immunol. 2021 May 28;12:684197
pubmed: 34122446
Exp Hematol. 2016 Feb;44(2):138-150.e1
pubmed: 26577566
Mol Med Rep. 2017 Nov;16(5):5887-5893
pubmed: 28849231
Semin Pediatr Surg. 2014 Dec;23(6):331-5
pubmed: 25459437

Auteurs

Yushi Abe (Y)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Daigo Ochiai (D)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Masako Taguchi (M)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Seiji Kanzaki (S)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.
StemCell Institute Inc., Tokyo 105-0004, Japan.

Satoru Ikenoue (S)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Yoshifumi Kasuga (Y)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Mamoru Tanaka (M)

Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH